Associated Papers
Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies.
Zayat V et al.
Cells, 2022
Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway.
Weng OY et al.
Frontiers in Molecular Neuroscience, 2022
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy.
Turner TJ et al.
Journal of Neurochemistry, 2021
Stem cells: A path towards improved epilepsy therapies.
Lybrand ZR et al.
Neuropharmacology, 2020
SCN1A variants from bench to bedside-improved clinical prediction from functional characterization.
Brunklaus A et al.
Human Mutation, 2020
Comparisons of dual isogenic human iPSC pairs identify functional alterations directly caused by an epilepsy associated SCN1A mutation.
Xie Y et al.
Neurobiology of Disease, 2020
Progress in the molecular mechanisms of genetic epilepsies using patient-induced pluripotent stem cells.
Zhou R et al.
Epilepsia Open, 2018
Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.
Traynelis J et al.
Genome Research, 2017
28864458 (PubMed )
Supplement: supp_gr.226589.117_Supplemental_Data_S1.xlsx › Data_S1
Model systems for studying cellular mechanisms of SCN1A-related epilepsy.
Schutte SS et al.
Journal of Neurophysiology, 2016
Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.
Tidball AM et al.
Stem Cells (dayton, Ohio), 2016
Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.
Jiao J et al.
Human Molecular Genetics, 2013
Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.
Srikanth P et al.
Journal of Neurogenetics, 0
Select a paper to view details